Drug-eluting stenting for femoropopliteal lesions, followed by cilostazol treatment, reduces stent restenosis in patients with symptomatic peripheral artery disease.

Zen, Kan

Drug-eluting stenting for femoropopliteal lesions, followed by cilostazol treatment, reduces stent restenosis in patients with symptomatic peripheral artery disease. [electronic resource] - Journal of vascular surgery Mar 2017 - 720-725 p. digital

Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial

1097-6809

10.1016/j.jvs.2016.10.098 doi


Aged
Aged, 80 and over
Cardiovascular Agents--administration & dosage
Cilostazol
Constriction, Pathologic
Drug-Eluting Stents
Endovascular Procedures--adverse effects
Female
Femoral Artery--diagnostic imaging
Humans
Japan
Logistic Models
Male
Middle Aged
Odds Ratio
Paclitaxel--administration & dosage
Peripheral Arterial Disease--complications
Platelet Aggregation Inhibitors--administration & dosage
Popliteal Artery--diagnostic imaging
Propensity Score
Prospective Studies
Prosthesis Design
Recurrence
Registries
Risk Factors
Tetrazoles--administration & dosage
Time Factors
Treatment Outcome
Ultrasonography, Doppler, Duplex
Vascular Patency--drug effects